Literature DB >> 1354663

Mechanism of action/effects of androgens on lipid metabolism.

M D Gillmer1.   

Abstract

The strongest predictors of cardiovascular disease in women have been shown to be diabetes, high blood pressure, cigarette smoking, and, to a lesser degree, hypertriglyceridemia. The difference in risk between men and premenopausal women has been explained by the following widely held hypothesis: androgens lower plasma concentrations of high-density lipoprotein (HDL), particularly the HDL-2 subfraction, and increase plasma concentrations of low-density lipoprotein (LDL). In contrast, estrogens have the opposite effect, raising plasma concentrations of HDL, particularly HDL-2, and lowering plasma concentrations of LDL. After the menopause, it is believed that the protective effect of estrogens in women is lost and the incidence of heart disease rises to equal that in men. This paper provides a brief review of the effect of endogenous and exogenous androgens on lipoprotein metabolism in men and women, and considers the relevance of these findings to the choice of progestogens used in oral contraceptive preparations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354663

Source DB:  PubMed          Journal:  Int J Fertil        ISSN: 0020-725X


  4 in total

1.  Lipoprotein receptor associated protein (LRPAP1) insertion/deletion polymorphism: association with gallbladder cancer susceptibility.

Authors:  Sachchida Nand Pandey; Manjusha Dixit; Gourdas Choudhuri; Balraj Mittal
Journal:  Int J Gastrointest Cancer       Date:  2006

2.  Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.

Authors:  Giuseppe Buono; Anna Crispo; Mario Giuliano; Carmine De Angelis; Francesco Schettini; Valeria Forestieri; Rossella Lauria; Michelino De Laurentiis; Pietro De Placido; Carmen Giusy Rea; Carmen Pacilio; Emanuela Esposito; Maria Grimaldi; Flavia Nocerino; Giuseppe Porciello; Aldo Giudice; Alfonso Amore; Anita Minopoli; Gerardo Botti; Sabino De Placido; Meghana V Trivedi; Grazia Arpino
Journal:  Breast Cancer Res Treat       Date:  2020-06-04       Impact factor: 4.872

3.  Biomarkers of the metabolic syndrome and breast cancer prognosis.

Authors:  Qiu-Li Zhu; Wang-Hong Xu; Meng-Hua Tao
Journal:  Cancers (Basel)       Date:  2010-04-28       Impact factor: 6.639

4.  Association of Dyslipidemia, Increased Insulin Resistance, and Serum CA 15-3 with Increased Risk of Breast Cancer in Urban Areas of North and Central India.

Authors:  Poonam Kachhawa; Kamal Kachhawa; Divya Agrawal; Vivek Sinha; Purnima Dey Sarkar; Sanjay Kumar
Journal:  J Midlife Health       Date:  2018 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.